Cellibre, Inc. — Form D
Cellibre, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-10-09. The offering totals $23.2M, of which $6.7M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-10-09
- Form: D
- Accession: 0001781232-24-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $23.2M
- Amount sold: $6.7M
- Remaining: $16.5M
- Minimum investment: $521
- Investors: 31
- Date of first sale: 2024-09-30
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-526229
Issuer
- Name: Cellibre, Inc.
- CIK: 0001781232
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 6825 FLANDERS DRIVE, SAN DIEGO, CA, 92121
- Phone: 916-539-5454
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Nicky Caiazza | Director | Encinitas, CA |
| Benjamin Chiarelli | Director | Rancho Santa Fe, CA |
| Spiros Kambourakis | Director | San Diego, CA |
| Scott Zingheim | Director | La Jolla, CA |
| Nicky Caiazza | Executive Officer | Encinitas, CA |
| Benjamin Chiarelli | Executive Officer | Rancho Santa Fe, CA |
| Spiros Kambourakis | Executive Officer | San Diego, CA |
| Scott Zingheim | Executive Officer | La Jolla, CA |
Other filings by this issuer (2)
More